Laggera crispata
Laggera crispata · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Laggera crispata is a botanical species recognized for its diverse pharmacological potential and therapeutic properties. Research indicates that its extracts possess significant anticancer and antioxidant activities, driven by bioactive compounds such as Chrysosplenetin B and Artemitin. These chemical constituents, including 1beta-hydroxy pterondontic acid and 6-O-beta-D-glucopyranosyl-carvotanacetone, contribute to the plant's medicinal efficacy. Studies suggest that the plant may be effective in addressing bacterial infections, fever, and Herpes Simplex Viruses. Furthermore, its unique chemical profile offers promising avenues for combating the growing challenge of drug resistance.
- Synonyms
- Conyza Crispata · Blumea Pterodonta · 11 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Laggera crispata is a unique plant known by several distinct regional names. In many English-speaking areas, it is commonly referred to as the Curly knob-bush. It also carries the local name katpisbossie, reflecting its cultural significance in certain regions. For those familiar with Chinese botanical nomenclature, the plant is recognized as 翼齒六棱菊. These diverse names highlight the plant's widespread presence and its varied identities across different languages.
Sources: Catalogue of Life (COL)
Synonyms
Laggera crispata is a botanical species that shares several taxonomic identities with various forms of the Blumea genus. It is recognized by multiple synonyms, including the widely used designation Blumea crispata. Furthermore, the plant is closely linked to the specific variety known as Blumea crispata var. montana. Scientific literature also classifies it under the names Blumea pterodonta and Blumea purpurascens. Finally, the nomenclature includes Blumea tetraptera, reflecting the complex historical relationships within its classification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Laggera crispata is a distinctive botanical specimen that belongs to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It further resides in the order Asterales, a group known for its diverse floral structures. As a member of the family Asteraceae, it shares evolutionary ties with many common sunflowers and daisies. Ultimately, this species is defined by its specific placement within the genus Laggera.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Laggera |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Laggera crispata is a botanical species with a wide distribution spanning several key regions across the African continent. In East Tropical Africa, it can be found flourishing within the borders of Kenya, Tanzania, and Uganda. The plant's reach extends further into Northeast Tropical Africa, where it establishes itself in the landscapes of Chad. Additionally, its presence is well-documented throughout the diverse environments of Ethiopia. This broad geographical range highlights the adaptability of the species across various African territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Laggera crispata is a self-supporting herb that grows with a sturdy and independent structure. This plant exhibits a versatile range of sizes depending on its environmental conditions. While it can reach a maximum height of 2 meters, it may also remain quite compact at only 0.3 meters. Such adaptability allows this species to thrive across various ecological niches.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Laggera crispata holds significant potential in the field of natural pharmacology due to its diverse biological properties. Research into its derivatives, such as the flavonoid Chrysosplenetin B, demonstrates that these compounds possess potent anticancer activity. Specifically, these substances have been shown to inhibit the proliferation of prostate cancer cells by inducing cell cycle arrest. Beyond their ability to combat malignancy, these natural products also exhibit valuable antioxidant effects. Consequently, exploring the bioactive components of this plant offers a promising pathway for developing new therapeutic agents.
Compounds
Laggera crispata, also known as Laggera pterodonta, serves as a rich source of diverse bioactive chemical constituents. Phytochemical analysis reveals that the plant contains several significant flavonoids, including quercetin, artemitin, and chrysosplenetin B. Research indicates that chrysosplenetin B specifically possesses the potential to inhibit the proliferation of prostate cancer cells by inducing cell cycle arrest. Additionally, the plant's chemical profile includes specialized compounds such as 6-O-beta-D-glucopyranosyl-carvotanacetone and 1beta-hydroxy pterondontic acid. These varied terpenoids and flavonoids highlight the medicinal importance of the species in pharmacological studies.
Conditions
Laggera crispata, particularly through species like L. pterodonta, serves as a valuable medicinal resource for treating bacterial infections and inflammation. The plant's bioactive constituents, such as Chrysosplenetin B, demonstrate a significant ability to treat castration-resistant prostate cancer (CRPC) by inducing G1 cell cycle arrest. Furthermore, its chemical properties help treat drug resistance and provide a promising defense against various drug-resistant pathogens. The plant also exhibits potent antiviral activity, which is effective in treating enteroviruses. These diverse therapeutic properties highlight the plant's potential for addressing complex medical challenges.
Preparations
Laggera crispata is prepared as extracts for various medicinal applications. These aqueous preparations are specifically studied for their potential bioactive properties. In the context of traditional herbal research, such extracts are screened for their antiviral activities. This preparation method allows for the evaluation of specific inhibitory effects against viruses. Consequently, the process of creating these extracts is essential for identifying their therapeutic potential.